On the fly News and insights, exclusive to thefly.com

HMC

Honda

$30.98 /

-0.235 (-0.75%)

, F

Ford

$13.56 /

+0.16 (+1.19%)

20:20
09/19/21
09/19
20:20
09/19/21
20:20

Fly Intel: Top five weekend stock stories

Catch up on the weekend's top five stories with this list compiled by The Fly: 1. U.S. auto safety investigators have opened a new probe into 30 million vehicles built by nearly two dozen automakers with potentially defective Takata air bag inflators, Reuters' David Shepardson reported, citing a government document seen by the publication. The National Highway Traffic Safety Administration on Friday opened an engineering analysis into an estimated 30 million U.S. vehicles from the 2001 through 2019 model years, the author noted, adding that automakers were alerted to the investigation, which is not yet public. The new investigation includes vehicles assembled by Honda Motor (HMC), Ford Motor (F), Toyota Motor (TM), General Motors (GM), Nissan (NSANY), Subaru (FUJHY), Tesla (TSLA), Ferrari NV (RACE), Mazda (MZDAY), Daimler AG (DDAIF), BMW (BMWYY), Chrysler (STLA), Porsche Cars (POAHY), Jaguar Land Rover (TTM) and others. 2. Investment firms Tiedemann Group and Alvarium Investments are close to a deal to merge and go public through a special-purpose acquisition company, The Wall Street Journal's Amrith Ramkumar reported, citing people familiar with the matter. The combined investment firm would be called Alvarium Tiedemann Holdings and be valued at roughly $1.4 billion in the deal with the SPAC Cartesian Growth Corp. (GLBL), the people said. The merger could be announced as soon as this week, the author noted. 3. In the earliest days of COVID-19 pandemic, investor and drug developers looked to antivirals to blunt the impact of the disease but didn't have much luck, with the only antiviral authorized by the Food and Drug Administration to date being Gilead's (GILD) Veklury, also known as remdesivir, Josh Nathan-Kazis wrote in this week's edition of Barron's. But the next generation of COVID-19 antivirals are now on the way, and a pill to treat - or even prevent - COVID-19 could be available by the end of the year. Merck (MRK), Pfizer (PFE), and the biotech Atea Pharmaceuticals (AVIR) each expect late-stage data on an oral COVID-19 antiviral in the coming months. If the data are positive, the drugs provide a major opportunity for the companies-one that investors should not ignore, the author noted. 4. Disney's (DIS) "Shang-Chi and the Legend of the Ten Rings" remained atop the box office charts in its third weekend, earning an estimated $21.7M from 4,070 theaters for a total North American ticket sales of $176.9M. The superhero movie sports an A Cinemascore and unlike fellow Marvel Studios pic "Black Widow," "Shang-Chi" has an exclusive 45-day theatrical release. 5. Apple (AAPL), Sanofi (SNY), BHP Group (BHP), Rio Tinto (RIO), Anglo American (NGLOY), Glencore (GLNCY), Vale (VALE), Wynn Resorts (WYNN) and Las Vegas Sands (LVS) saw positive mentions in this week's edition of Barron's, while Nike (NKE) was mentioned cautiously.

HMC

Honda

$30.98 /

-0.235 (-0.75%)

F

Ford

$13.56 /

+0.16 (+1.19%)

TM

Toyota

$180.91 /

-0.95 (-0.52%)

GM

General Motors

$51.34 /

-0.18 (-0.35%)

NSANY

Nissan

$10.37 /

-0.1415 (-1.35%)

FUJHY

Subaru

$9.41 /

-0.085 (-0.90%)

TSLA

Tesla

$759.92 /

+2.995 (+0.40%)

RACE

Ferrari

$216.51 /

-2.4 (-1.10%)

MZDAY

Mazda Motor

$4.30 /

-0.05 (-1.15%)

DDAIF

Daimler AG

$83.55 /

-1.46 (-1.72%)

BMWYY

BMW

$31.48 /

-0.905 (-2.79%)

STLA

Stellantis

$19.78 /

-0.825 (-4.00%)

TTM

Tata Motors

$20.68 /

-0.35 (-1.66%)

GLBL

Cartesian Growth

$9.75 /

+0.05 (+0.52%)

GILD

Gilead

$71.61 /

+0.34 (+0.48%)

PFE

Pfizer

$43.89 /

-0.57 (-1.28%)

MRK

Merck

$71.70 /

-0.25 (-0.35%)

AVIR

Atea Pharmaceuticals

$26.23 /

-0.9 (-3.32%)

DIS

Disney

$183.50 /

+0.205 (+0.11%)

BHP

BHP Group

$55.53 /

-2.57 (-4.42%)

RIO

Rio Tinto

$68.05 /

-2.1 (-2.99%)

NGLOY

Anglo American

$18.06 /

-1.5899 (-8.09%)

GLNCY

Glencore

$9.01 /

-0.17 (-1.85%)

VALE

Vale

$16.30 /

-0.42 (-2.51%)

NKE

Nike

$156.41 /

-1.21 (-0.77%)

AAPL

Apple

$146.00 /

-2.84 (-1.91%)

SNY

Sanofi

$48.35 /

+0.14 (+0.29%)

WYNN

Wynn Resorts

$83.30 /

-1.095 (-1.30%)

LVS

Las Vegas Sands

$38.17 /

+0.66 (+1.76%)

  • 21

    Sep

  • 23

    Sep

  • 24

    Sep

  • 27

    Sep

  • 06

    Oct

  • 07

    Oct

  • 19

    Oct

  • 28

    Oct

  • 08

    Nov

  • 28

    Nov

  • 04

    Dec

  • 10

    Dec

  • 21

    Dec

  • 29

    Dec

  • 21

    Mar

  • 28

    Mar

  • 06

    May

  • 30

    Oct

  • 09

    Feb

HMC Honda
$30.98 /

-0.235 (-0.75%)

02/18/21 Daiwa
Honda downgraded to Outperform from Buy at Daiwa
F Ford
$13.56 /

+0.16 (+1.19%)

09/08/21 Benchmark
Worst of chip shortage could be over for Ford, says Benchmark
07/16/21 BofA
Ford price target raised to $18 from $17 at BofA
06/29/21 UBS
Ford price target raised to $16 from $13 at UBS
06/22/21 Barclays
Ford price target raised to $17 from $15 at Barclays
TM Toyota
$180.91 /

-0.95 (-0.52%)

09/16/21 Morgan Stanley
XPeng 'aiming to redefine mass-market EVs' with P5, says Morgan Stanley
03/30/21 Citi
Toyota resumed with a Buy at Citi
GM General Motors
$51.34 /

-0.18 (-0.35%)

09/13/21 Barclays
General Motors price target lowered to $68 from $71 at Barclays
08/09/21 Jefferies
General Motors price target lowered to $53 from $68 at Jefferies
08/05/21 JPMorgan
GM post-earnings selloff 'seems overblown,' says JPMorgan
08/05/21 Deutsche Bank
General Motors investors should look past headwinds, says Deutsche Bank
NSANY Nissan
$10.37 /

-0.1415 (-1.35%)

07/29/21 CLSA
Nissan upgraded to Buy from Underperform at CLSA
02/16/21 Wedbush
Wedbush expects Apple to announce formal EV partnership in 2021
12/21/20 SMBC Nikko
Nissan upgraded to Neutral from Underperform at SMBC Nikko
10/28/20 Jefferies
Nissan upgraded to Hold from Underperform at Jefferies
FUJHY Subaru
$9.41 /

-0.085 (-0.90%)

03/17/21 Goldman Sachs
Subaru downgraded to Neutral from Buy at Goldman Sachs
TSLA Tesla
$759.92 /

+2.995 (+0.40%)

09/17/21 Morgan Stanley
520 mile EPA range 'an important milestone' for Lucid, says Morgan Stanley
09/17/21 Wedbush
Tesla EV demand story just starting to play out, says Wedbush
09/15/21 BofA
BofA calls Lucid the 'Tesla/Ferrari of new EV automakers,' starts at Buy
09/10/21 Craig-Hallum
VIA Optronics price target lowered to $14 from $18 at Craig-Hallum
RACE Ferrari
$216.51 /

-2.4 (-1.10%)

09/16/21 Exane BNP Paribas
Ferrari cut to Neutral at Exane BNP Paribas on slow cyclical recovery
09/16/21 Exane BNP Paribas
Ferrari downgraded to Neutral from Outperform at Exane BNP Paribas
09/09/21 Oddo BHF
Ferrari initiated with an Outperform at Oddo BHF
MZDAY Mazda Motor
$4.30 /

-0.05 (-1.15%)

08/17/21 Credit Suisse
Mazda Motor upgraded to Neutral from Underperform at Credit Suisse
06/24/21 UBS
Mazda Motor upgraded to Buy from Sell at UBS
10/13/20 Citi
Mazda Motor upgraded to Neutral from Sell at Citi
DDAIF Daimler AG
$83.55 /

-1.46 (-1.72%)

09/17/21 JPMorgan
Daimler AG price target lowered to EUR 98 from EUR 100 at JPMorgan
08/11/21 Barclays
Daimler AG price target lowered to EUR 110 from EUR 115 at Barclays
08/09/21 Jefferies
Daimler AG downgraded to Hold from Buy at Jefferies
08/01/21 Goldman Sachs
Daimler AG upgraded to Conviction Buy from Buy at Goldman Sachs
BMWYY BMW
$31.48 /

-0.905 (-2.79%)

09/17/21 JPMorgan
BMW price target lowered to EUR 88 from EUR 95 at JPMorgan
09/15/21 Deutsche Bank
BMW named short-term investment idea at Deutsche Bank
08/20/21 Erste Group
BMW downgraded to Hold from Buy at Erste Group
08/11/21 Barclays
BMW price target lowered to EUR 95 from EUR 108 at Barclays
STLA Stellantis
$19.78 /

-0.825 (-4.00%)

09/07/21 KeyBanc
Jeep micro site on Amazon points to auto sales moving online, says KeyBanc
09/03/21 Deutsche Bank
Stellantis deal 'significant opportunity' for Open Lending, says Deutsche Bank
09/02/21 DA Davidson
DA Davidson says Stellantis opportunity for Open Lending not 'fait accompli'
09/02/21 Raymond James
Raymond James says buy Open Lending aggressively after Stellantis deal
TTM Tata Motors
$20.68 /

-0.35 (-1.66%)

06/30/21 Jefferies
Tata Motors assumed with a Buy at Jefferies
06/29/21 Nomura
Tata Motors upgraded to Neutral from Reduce at Nomura
02/05/21 UBS
Tata Motors upgraded to Neutral from Sell at UBS
GLBL Cartesian Growth
$9.75 /

+0.05 (+0.52%)

GILD Gilead
$71.61 /

+0.34 (+0.48%)

09/09/21 RBC Capital
Biden drug reform plan has 'few new concepts or specifics,' says RBC Capital
07/30/21 BMO Capital
Gilead price target raised to $72 from $67 at BMO Capital
07/30/21 RBC Capital
Gilead price target raised to $84 from $81 at RBC Capital
06/29/21 Jefferies
Gilead data should move Yescarta up to second line in DLBCL, says Jefferies
PFE Pfizer
$43.89 /

-0.57 (-1.28%)

09/17/21 Evercore ISI
Evercore ISI doesn't think FDA panel will recommend COVID-19 boosters
09/16/21 Canaccord
Exact Sciences salesforce expansion a net positive, says Canaccord
09/16/21 BofA
Moderna boosters already reflected in 'bullish' consensus, says BofA
09/15/21 Raymond James
Exact Sciences' 'opportunistic' hires should boost sales, says Raymond James
MRK Merck
$71.70 /

-0.25 (-0.35%)

09/07/21
Fly Intel: Top five analyst downgrades
09/07/21 Morgan Stanley
Morgan Stanley downgrades Merck to Equal Weight, awaits strategic action
09/07/21 Morgan Stanley
Merck downgraded to Equal Weight from Overweight at Morgan Stanley
AVIR Atea Pharmaceuticals
$26.23 /

-0.9 (-3.32%)

09/09/21 SVB Leerink
Atea Pharmaceuticals initiated with an Outperform at SVB Leerink
04/16/21 William Blair
Atea selloff on Merck update unwarranted, says William Blair
01/29/21 JPMorgan
Atea Pharmaceuticals price target raised to $66 from $45 at JPMorgan
11/24/20 Evercore ISI
Atea Pharmaceuticals initiated with an Outperform at Evercore ISI
DIS Disney
$183.50 /

+0.205 (+0.11%)

09/13/21 Stephens
Recent Apple TV+ news positive for Roku, says Stephens
09/10/21 Truist
Apple will likely appeal ruling in Epic case, says Truist
09/09/21 Arete
Disney initiated with a Buy at Arete
08/30/21 JPMorgan
Movie executives see 10% of screens closing, down from 15%, says JPMorgan
BHP BHP Group
$55.53 /

-2.57 (-4.42%)

09/14/21 Barclays
BHP Group downgraded to Equal Weight from Overweight at Barclays
08/18/21 RBC Capital
BHP Group price target lowered to 2,300 GBp from 2,400 GBp at RBC Capital
07/30/21 CLSA
Rio Tinto downgraded to Sell from Underperform at CLSA
07/08/21 Berenberg
BHP Group upgraded to Buy from Hold at Berenberg
RIO Rio Tinto
$68.05 /

-2.1 (-2.99%)

09/17/21 Morgan Stanley
Rio Tinto price target lowered to 5,410 GBp from 6,330 GBp at Morgan Stanley
09/17/21 UBS
Rio Tinto price target lowered to A$86 from A$102 at UBS
09/16/21 Deutsche Bank
Rio Tinto price target lowered to 6,000 GBp from 6,600 GBp at Deutsche Bank
09/14/21 Barclays
Rio Tinto price target lowered to 4,900 GBp from 6,000 GBp at Barclays
NGLOY Anglo American
$18.06 /

-1.5899 (-8.09%)

09/17/21 Morgan Stanley
Anglo American downgraded to Equal Weight from Overweight at Morgan Stanley
09/17/21 UBS
Anglo American downgraded to Sell from Neutral at UBS
09/16/21 Deutsche Bank
Anglo American price target lowered to 3,600 GBp at Deutsche Bank
09/14/21 Barclays
Anglo American price target lowered to 3,600 GBp from 3,700 GBp at Barclays
GLNCY Glencore
$9.01 /

-0.17 (-1.85%)

09/17/21 Morgan Stanley
Glencore upgraded to Overweight from Equal Weight at Morgan Stanley
09/16/21 RBC Capital
Glencore price target raised to 400 GBp from 360 GBp at RBC Capital
09/16/21 Deutsche Bank
Glencore price target raised to 440 GBp from 420 GBp at Deutsche Bank
09/16/21 RBC Capital
Glencore price target raised to 400 GBp from 360 GBp at RBC Capital
VALE Vale
$16.30 /

-0.42 (-2.51%)

09/17/21 UBS
Vale downgraded to Sell from Buy at UBS
07/15/21 HSBC
Vale price target raised to $27 from $25 at HSBC
07/12/21 Scotiabank
Vale price target raised to $26 from $24 at Scotiabank
07/02/21 RBC Capital
Vale price target lowered to $27 from $29 at RBC Capital
NKE Nike
$156.41 /

-1.21 (-0.77%)

09/13/21
Fly Intel: Top five analyst downgrades
09/13/21 BTIG
BTIG downgrades Nike on 'severe supply chain disruptions' in Vietnam
09/13/21 BTIG
Nike downgraded to Neutral from Buy at BTIG
09/09/21 UBS
Nike more likely to rise than fall after Q1 results, says UBS
AAPL Apple
$146.00 /

-2.84 (-1.91%)

09/17/21 Jefferies
Snap Q3 revenue estimates too low, says Jefferies
09/15/21 Oppenheimer
Apple's iPhone 13 likely to attract upgraders, says Oppenheimer
09/15/21 Deutsche Bank
Apple iPhone changes 'more incremental than transformative,' says Deutsche Bank
09/15/21 Morgan Stanley
Improved iPhone affordability raises Morgan Stanley confidence in Apple growth
SNY Sanofi
$48.35 /

+0.14 (+0.29%)

09/14/21 Mizuho
Kadmon downgraded to Neutral from Buy at Mizuho
09/10/21 UBS
Kadmon downgraded to Neutral from Buy at UBS
09/09/21 Benchmark
Sanofi deal for Kadmon reinforces Incyte thesis, says Benchmark
WYNN Wynn Resorts
$83.30 /

-1.095 (-1.30%)

09/17/21
Fly Intel: Top five analyst downgrades
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/17/21 Argus
Wynn Resorts downgraded to Hold from Buy at Argus
09/16/21 JPMorgan
Wynn Resorts downgraded on Macau uncertainty at JPMorgan
LVS Las Vegas Sands
$38.17 /

+0.66 (+1.76%)

09/17/21 Jefferies
Jefferies downgrades Las Vegas Sands on 'growth uncertainty' in Macau
09/17/21 Jefferies
Las Vegas Sands downgraded to Hold from Buy at Jefferies
09/16/21 JPMorgan
JPMorgan downgrades Las Vegas Sands on Macau uncertainty

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.